Table 3.
Treatment | PPARγ (%) | C/EBPα (%) |
---|---|---|
PG 1 mg/mL | 19.54 ± 3.62* | 32.92 ± 3.34* |
VN 1 mg/mL | 26.85 ± 2.69** | 30.92 ± 2.99* |
PG-VN combination 1 mg/mL | 35.75 ± 2.07∗∗a | 36.32 ± 4.34** |
PG-VN combination 2 mg/mL | 30.19 ± 1.30∗∗a | 39.88 ± 4.15** |
xPG + VN | 46.39 ± 6.31 | 63.84 ± 6.33 |
x(PG + VN)/2 | 23.195 ± 3.155 | 31.92 ± 3.165 |
Values were expressed as means ± SD. *P < 0.05, significantly different from the Control; **P < 0.005, significantly different from the control; a P < 0.05, significantly different from PG. xCalculated additive response (the sum of the effects of the individual PG and VN treatments). Control, expression of the differentiated 3T3-L1 cells was considered as 0%; PG: Panax ginseng; VN: Veratrum nigrum.